Madrigal Pharmaceuticals Inc (MDGL)
302.67
-12.48
(-3.96%)
USD |
NASDAQ |
Nov 14, 16:00
303.04
+0.37
(+0.12%)
After-Hours: 20:00
Madrigal Pharmaceuticals Total Return Level: 302.67 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 302.67 |
November 13, 2024 | 315.15 |
November 12, 2024 | 339.04 |
November 11, 2024 | 339.66 |
November 08, 2024 | 350.70 |
November 07, 2024 | 354.85 |
November 06, 2024 | 338.22 |
November 05, 2024 | 337.61 |
November 04, 2024 | 331.32 |
November 01, 2024 | 319.58 |
October 31, 2024 | 259.34 |
October 30, 2024 | 215.93 |
October 29, 2024 | 217.79 |
October 28, 2024 | 217.00 |
October 25, 2024 | 210.67 |
October 24, 2024 | 202.99 |
October 23, 2024 | 202.48 |
October 22, 2024 | 203.59 |
October 21, 2024 | 208.89 |
October 18, 2024 | 214.44 |
October 17, 2024 | 210.47 |
October 16, 2024 | 215.60 |
October 15, 2024 | 216.17 |
October 14, 2024 | 215.43 |
October 11, 2024 | 214.15 |
Date | Value |
---|---|
October 10, 2024 | 210.58 |
October 09, 2024 | 210.88 |
October 08, 2024 | 216.77 |
October 07, 2024 | 214.83 |
October 04, 2024 | 208.41 |
October 03, 2024 | 206.58 |
October 02, 2024 | 209.15 |
October 01, 2024 | 209.33 |
September 30, 2024 | 212.22 |
September 27, 2024 | 212.43 |
September 26, 2024 | 213.90 |
September 25, 2024 | 216.21 |
September 24, 2024 | 223.07 |
September 23, 2024 | 225.72 |
September 20, 2024 | 233.49 |
September 19, 2024 | 242.25 |
September 18, 2024 | 233.16 |
September 17, 2024 | 233.36 |
September 16, 2024 | 233.39 |
September 13, 2024 | 241.80 |
September 12, 2024 | 234.76 |
September 11, 2024 | 233.00 |
September 10, 2024 | 235.69 |
September 09, 2024 | 238.69 |
September 06, 2024 | 243.89 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
55.89
Minimum
Jan 27 2022
354.85
Maximum
Nov 07 2024
147.54
Average
115.94
Median
Total Return Level Benchmarks
ADMA Biologics Inc | 20.20 |
89bio Inc | 8.75 |
Corcept Therapeutics Inc | 54.79 |
Sarepta Therapeutics Inc | 109.11 |
Matinas BioPharma Holdings Inc | 0.6344 |